152
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Characterization of blood vessels in bone marrow from patients with chronic myeloid leukemia and polycythemia vera

, &
Pages 641-648 | Published online: 08 Jul 2009

References

  • Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990; 82: 4 — 6.
  • Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 1991; 324: 1–8.
  • Bodey B, Bodey B, Jr, Siegel SE, Kaiser HE. Immunocytochemical detection of endoglin is indicative of angiogenesis in malignant melanoma. Anticancer Res 1998; 18: 2701–10.
  • Aguayo A, Kantarjian H, Manshouri T, Gidel C, Estey E, Thomas D, Coller C, Estrov Z, O'Brien S, Keating M, Freirech E, Albitar M. Angiogen-esis in acute and chronic leukemias and myelo-dysplastic syndromes. Blood 2000; 96: 2240–5.
  • Lundberg LG, Lerner R, Sundelin P, Rogers R, Folkman J, Palmblad J. Bone marrow in poly-cythemia vera, chronic myelocytic leukemia, and myelofibrosis has an increased vascularity. Am J Pathol 2000; 157: 15–9.
  • Wurmbach JH, Hammerer P, Sevinc S, Huland H, Ergun S. The expression of angiopoietins and their receptor Tie-2 in human prostate carcinoma. Anticancer Res 2000; 20: 5217–20.
  • Nakashima M, Uchida T, Tsukazaki T, Hamanaka Y, Fukuda E, Ito M, Sekine I. Expression of tyrosine kinase receptors Tie-1 and Tie-2 in giant cell tumor of the tendon sheath: a possible role in synovial proliferation. Pathol Res Pract 2001; 197: 101–7.
  • Fonsatti E, Del Vecchio L, Altomonte M. Endoglin: an accessory component of the TGF-beta-binding receptor-complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies. J Cell Physiol 2001; 188: 1–7.
  • Bodey B, Bodey B, Jr, Siegel SE, Kaiser HE. Over-expression of endoglin (CD105): a marker of breast carcinoma-induced neo-vascularization. Anticancer Res 1998; 18: 3621–8.
  • Kirschenbaum A, Liu X, Yao S, Levine AC. The role of cyclooxygenase-2 in prostate cancer. Urology 2001; 58: 127–31.
  • Masferrer JL, Leahy KM, Koki AT, Zweifel BS, Settle SL, Woerner BM, Edwards DA, Flickinger AG, Moore RJ, Seibert K. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibi-tors. Cancer Res 2000; 60: 1306–11.
  • Akaogi K, Okabe Y, Sato J, Nagashima Y, Yasumitsu H, Sugahara K, Miyazaki K. Specific accumulation of tumor-derived adhesion factor in tumor blood vessels and in capillary tube-like structures of cultured vascular endothelial cells. Proc Natl Acad Sci USA 1996; 93: 8384 — 9.
  • Adachi Y, Itoh F, Yamamoto H, Arimura Y, Kikkawa-Okabe Y, Miyazaki K, Carbone DP, Imai K. Expression of angiomodulin (tumor-derived adhesion factor/mac25) in invading tumor cells correlates with poor prognosis in human colorectal cancer. Int J Cancer 2001; 95: 216— 22.
  • Zhou HM, Ramachandran S, Kim JG, Raynor DB, Rock JA, Parthasarathy S. Implications in the management of pregnancy: II. Low levels of gene expression but enhanced uptake and accumulation of umbilical cord glycodelin. Fertil Steril 2000; 73: 843–7.
  • Kamarainen M, Riittinen L, Seppala M, Palotie A, Andersson LC. Progesterone-associated endo-metrial protein: a constitutive marker of human erythroid precursors. Blood 1994; 84: 467–73.
  • Zetterberg E, Lundberg LG, Palmblad J. Expres-sion of Cox-2, Tie-2 and glycodelin by megakar-yocytes in patients with chronic myeloid leukaemia and polycythaemia vera. Br J Haematol 2003; 121: 497 — 9.
  • Schnurch H, Risau W. Expression of Tie-2, a member of a novel family of receptor tyrosine kinases, in the endothelial cell lineage. Develop-ment 1993; 119: 957 — 68.
  • Iwama A, Hamaguchi I, Hashiyama M, Murayama Y, Yasunaga K, Suda T. Molecular cloning and characterization of mouse TIE and TEK receptor tyrosine kinase genes and their expression in hematopoietic stem cells. Biochem Biophys Res Commun 1993; 195: 301–9.
  • Barry FP, Boynton RE, Haynesworth S, Murphy JM, Zaia J. The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105). Biochem Bio-phys Res Commun 1999; 265: 134 — 9.
  • Kamarainen M, Leivo I, Koistinen R, Julkunen M, Karvonen U, Rutanen EM, Seppala M. Normal human ovary and ovarian tumors express glycodelin, a glycoprotein with immunosuppressive and contraceptive properties. Am J Pathol 1996; 148: 1435 —43.
  • Morrow DM, Xiong N, Getty RR, Ratajczak MZ, Morgan D, Seppala M, Riittinen L, Gewirtz AM, Tykocinski ML. Hematopoietic placental protein 14. An immunosuppressive factor in cells of the megakaryocytic lineage. Am J Pathol 1994; 145: 1485 — 95.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.